Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.36921 | 14 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.32888 | 13 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.34418 | 14 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.28546 | 13 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.28372 | 13 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.3809 | 13 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.36165 | 14 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.31906 | 13 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.31044 | 13 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.3322 | 14 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.32777 | 14 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.30831 | 13 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.32956 | 13 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.32448 | 13 |